Arca
Skip to content
Tools
Tools

ClearTip FNA and FNB Types

Biopsy Needle. 510(k) K250994, from Finemedix Co., Ltd. (Daegu, KR). Product code FCG, class 2.

As of Nov 18, 2026, K250994 is an FDA 510(k) held by Finemedix Co., Ltd., substantially equivalent on Aug 21, 2025 after 142 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Aug 21, 2025
  • Review time: 142 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The ClearTip FNA and FNB Types are intended for Ultrasonically Guided Fine Needle Aspiration, (FNA) of submucosal and extraluminal lesions of the Gastrointestinal Tract, (e.g., lymph nodes, abnormal tissue in the mediastinum). 7

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF
  • ClearTipK231267 · Finemedix Co., Ltd. · Jun 30, 2023

Other FCG Clearances

The newest 510(k)s for the same product code; their median review was 103 days; see every FCG device

Record

Type
Traditional
Received
Apr 1, 2025
Review panel
Gastroenterology, Urology
Regulation
21 CFR 876.1075

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.